NEWS

2022.08.03

Press Releases

Announcement of Appointment of Outside Director

2022.06.30

Press Releases

Conclusion of Joint Development Agreement for Corneal Endothelial Regenerative Medicine Product AE-101, and Series B Funding through Third-Party Allocation of Shares

2022.05.31

Press Releases

Santen and ActualEyes start registering patients to participate in Phase II clinical trial （Phase IIa / PoC study, PHANTOM study）for Fuchs endothelial corneal dystrophy

2021.11.18

Press Releases

Santen and ActualEyes sign a joint development agreement on Phase II clinical trial (Phase II a / PoC study) for a treatment candidate for Fuchs endothelial corneal dystrophy

2021.05.14

Press Releases

ActualEyes and Arctic Vision announce a licensing agreement to develop and commercialize ActualEyes’ lead product candidate, AE101

This website uses cookies for the purpose of operating our services and improving the user experience. For details, please refer to our privacy policy. By clicking on the “Agree” button or continuing to use our website, you will be regarded as having agreed to our use of cookies.